UBS Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,462
Closed -$4.27K 8805
2023
Q1
$4.27K Buy
6,462
+5,838
+936% +$3.85K ﹤0.01% 7112
2022
Q4
$936 Buy
624
+347
+125% +$521 ﹤0.01% 8827
2022
Q3
$1K Sell
277
-3,582
-93% -$12.9K ﹤0.01% 9026
2022
Q2
$22K Buy
3,859
+3,370
+689% +$19.2K ﹤0.01% 5751
2022
Q1
$6K Sell
489
-213
-30% -$2.61K ﹤0.01% 7972
2021
Q4
$7K Buy
702
+235
+50% +$2.34K ﹤0.01% 8067
2021
Q3
$15K Sell
467
-1,753
-79% -$56.3K ﹤0.01% 6392
2021
Q2
$95K Buy
+2,220
New +$95K ﹤0.01% 4885
2021
Q1
Sell
-74
Closed -$3K 8353
2020
Q4
$3K Sell
74
-672
-90% -$27.2K ﹤0.01% 7002
2020
Q3
$30K Buy
+746
New +$30K ﹤0.01% 5147
2019
Q4
Sell
-18
Closed -$3K 7258
2019
Q3
$3K Buy
+18
New +$3K ﹤0.01% 6705
2019
Q2
Sell
-39
Closed -$15K 7208
2019
Q1
$15K Buy
39
+37
+1,850% +$14.2K ﹤0.01% 5722
2018
Q4
$1K Sell
2
-14
-88% -$7K ﹤0.01% 6994
2018
Q3
$7K Buy
16
+8
+100% +$3.5K ﹤0.01% 6431
2018
Q2
$3K Sell
8
-35
-81% -$13.1K ﹤0.01% 6736
2018
Q1
$20K Buy
43
+28
+187% +$13K ﹤0.01% 5552
2017
Q4
$9K Sell
15
-4
-21% -$2.4K ﹤0.01% 6138
2017
Q3
$14K Buy
19
+16
+533% +$11.8K ﹤0.01% 5802
2017
Q2
$2K Buy
3
+1
+50% +$667 ﹤0.01% 6458
2017
Q1
$1K Hold
2
﹤0.01% 6550
2016
Q4
$1K Sell
2
-4
-67% -$2K ﹤0.01% 6658
2016
Q3
$6K Buy
6
+4
+200% +$4K ﹤0.01% 6144
2016
Q2
$2K Hold
2
﹤0.01% 6532
2016
Q1
$2K Hold
2
﹤0.01% 6456
2015
Q4
$2K Sell
2
-11
-85% -$11K ﹤0.01% 6609
2015
Q3
$19K Sell
13
-4
-24% -$5.85K ﹤0.01% 5495
2015
Q2
$36K Buy
17
+11
+183% +$23.3K ﹤0.01% 5027
2015
Q1
$18K Sell
6
-4
-40% -$12K ﹤0.01% 5460
2014
Q4
$33K Buy
+10
New +$33K ﹤0.01% 5082